Healthtech Startups

Neurotype provides AI software that helps clinicians convert multi-source case evidence (interviews, developmental histories, questionnaires, school input, GP letters, assessment notes) into structured, clinic-formatted draft diagnostic reports for ADHD and autism assessments, with the clinician retaining responsibility for judgment and sign-off. It targets neurodevelopmental diagnostic clinics across the UK and Ireland, aiming to cut report-writing time and increase assessment capacity.

1 investor

NeuroVigil develops portable, single-channel EEG brain-monitoring technology and analysis software for neurological research, disease diagnosis, and pharmaceutical clinical trials. Its systems are used to monitor sleep and brain activity for conditions such as ALS, Alzheimer's, and Parkinson's, serving researchers, drug developers, and patients.

1 investor

NeuroVirt provides mixed reality therapy software for stroke and neurorehabilitation, offering gamified exercises for upper and lower limb recovery in clinical and home settings with real-time motion tracking and clinician dashboards.

1 investor

Neurum uses digital behavioral data and machine learning to generate mental-health indicators and individualized care pathways. It is sold to employers and care providers, who receive risk forecasts, intervention prompts, and analytics for tracking changes in workforce wellbeing over time.

1 investor

Neutrolis is a clinical-stage biotech developing first-in-class therapies that degrade neutrophil extracellular traps (NETs) to address the root cause of autoimmune and inflammatory diseases such as lupus and rheumatoid arthritis. Its approach targets the process of NETosis to treat these disorders without relying on immunosuppression.

1 investor

Neutun is a Canadian health technology company that develops software for monitoring epileptic seizures using commercially available wearable devices. Its application handles continuous passive monitoring, medication reminders, alerts, and progress logging. The tool is aimed at people managing epilepsy and other chronic or acute conditions who need a record of their events.

1 investor

Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders. The company translates research on brain vasculature and the blood-brain barrier into drug development programs.

1 investor

NEUVOGEN is a biotechnology company developing therapeutic cancer vaccines, using a whole tumor cell vaccine platform aimed at addressing the complexity of solid tumors.

1 investor

NEVAP develops airway management devices, including a subglottic suction endotracheal tube designed to drain tracheal secretions and reduce the risk of ventilator-associated and other pneumonias in ventilated patients. Its products are aimed at clinical settings such as the ICU, operating room, and emergency department.

1 investor

nevisQ makes the nevisCura bed sensor, a fall-prevention device that mounts on care beds and detects when a resident is getting out of bed, then alerts nursing staff through existing nurse-call, telephone, or emergency-call systems. It serves care homes, senior residences, and hospitals across Germany, Austria, Switzerland, Belgium, Luxembourg, and Spain.

1 investor

New Frontier Bio is a biotechnology company with a cross-functional management team experienced in start-ups, science, strategy, and M&A across healthcare, biotechnology, and cosmetics.

1 investor

New Incentives runs conditional cash transfer programs that encourage mothers in Nigeria to have their infants immunized against preventable diseases. It operates as a nonprofit focused on public health in Nigeria.

1 investor

New Life Minds develops technology combining healthcare, life sciences, synthetic biology, and machine learning, with a stated focus on advancing brain evolution.

1 investor

An independent nonprofit academic research institution that convenes talent from academic, research, and medical institutions to advance collaborative genomic research and accelerate discoveries in the genetic basis of disease for clinical diagnosis and treatment.

1 investor

New Zealand Clinical Research (NZCR) is a clinical trials and medical research organization that conducts early-phase and later-phase clinical research for pharmaceutical, biotech, and contract research organizations. With over 35 years of experience and multiple facilities across New Zealand, the organization specializes in testing new medicines and treatments across various therapeutic areas including gene therapy, hepatology, and vaccines.

1 investor

New Day Healthcare invests in home care and hospice businesses, providing capital and operational expertise from seasoned industry leaders to support patient-centered outcomes. The firm partners with home care operators who share its values of clinical quality, financial responsibility, and mission-driven stewardship.

1 investor

NewGen Health is developing an at-home care management platform, including a SmartCup device that analyzes urine samples and vital signs at home, with results and trends shared with patients' care teams via cloud storage and EMR integration. It targets monitoring for chronic kidney disease, expectant mothers, and diabetes/cardio-metabolic care, with a stated focus on health equity and accessible care.

1 investor

New Look Vision Group is an optical retailer that sells eyewear, ophthalmic lenses, and eyecare services through a portfolio of retail banners across Canada and the United States. It operates chains and boutiques including New Look Eyewear, IRIS, Vogue Optical, Greiche & Scaff, and several U.S. luxury optical brands.

1 investor

Newronika is a spin-off of Italian research institutions Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and the University of Milan that develops adaptive deep brain stimulation (αDBS) technology which responds to brain activity in real time. Its neuromodulation systems target Parkinson's disease and are being studied for a broader range of brain disorders, serving clinicians and patients.

1 investor

Newton is an innovation company that develops therapeutic optical lenses for treating eye-related conditions like headaches, motion sickness, and neck pain caused by eye misalignment. The company serves optometrists and patients across North America and Europe in the healthcare and optical devices sector.

1 investor

Newton builds a unified phone system platform for dental practices, integrating AI receptionist capabilities with traditional staff workflows to replace fragmented communication tools. The platform serves dental offices looking to streamline multi-location call management and operations.

1 investor

Nexben provides technology for managing health benefits, including an ICHRA platform for administering health benefit payments and plan administration for benefit consultants and employers, and an FMO offering that supports brokers with tools and resources across Medicare, individual health, ancillary, and group products. It serves benefit consultants, employers, and insurance brokers in the health benefits industry.

1 investor

Nexe Fundació is a non-profit organization that provides services and support for children with multiple disabilities and their families, developing innovative therapeutic and assistive technology solutions. The foundation works to improve quality of life, autonomy, and social inclusion while conducting research and training professionals.

1 investor

Nexeye is a European optical retail leader operating multiple brands including eyes + more, Hans Anders, and Direkt Optik, providing eye and hearing care services through an omnichannel platform of over 760 stores. The company serves consumers across Europe seeking affordable, high-quality vision and hearing solutions.

1 investor